CRISPR Therapeutics Provides Business Update and Reports First Quarter 2018 Financial Results – GlobeNewswire (press release)
Post Analyst |
CRISPR Therapeutics Provides Business Update and Reports First Quarter 2018 Financial Results
GlobeNewswire (press release) ZUG, Switzerland and CAMBRIDGE, Mass., May 08, 2018 (GLOBE NEWSWIRE) — CRISPR Therapeutics (NASDAQ:CRSP), a biopharmaceutical company focused on developing transformative gene-based medicines for serious diseases, today provided a business update and … Investors Jumping Ship on Skechers USA, Inc. (SKX), CRISPR Therapeutics AG (CRSP) The Market's 4 Best Stocks to Buy Right Now |
